2 protocol(s) meet the specified criteria
PI: Rose, Tracy
Protocol No.TitleStatus
WO39210A Phase III, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Atezolizumab (Anti−PD-L1 Antibody) As Adjuvant Therapy in Patients with Renal Cell Carcinoma at High Risk of Developing Metastasis Following NephrectomyOpen
X4P-001-RCCBA Phase 1b/2a Trial Adding X4P-001 in Patients Receiving Nivolumab for Treatment of Advanced Clear Cell Renal Cell CarcinomaOpen